Purpose: The objectives of this study were: 1) to determine the accuracy of dual-phase 99m Tc -methoxyisobutylisonitrile (MIBI) with singlephoton emission computed tomography/computed tomography (SPECT/CT) for the preoperative localization of parathyroid adenomas in the setting of primary hyperparathyroidism; 2) to determine the accuracy of localization for ectopic glands; and 3) to assess the relationship between accuracy and serum parathyroid hormone (PTH) levels. Methods: Eighty-eight patients who underwent 99m Tc-MIBI SPECT/CT imaging for primary hyperparathyroidism at our institution over a 27-month period were retrospectively assessed. The preoperative SPECT/CT results were compared to intraoperative findings (within 1 year of imaging). The relationship between serum PTH level (within 3 months) and SPECT/CT accuracy was then evaluated. Results: Accuracy indices for the retrothyroid subgroup were sensitivity 86.7%, specificity 96.4%, positive predictive value 98.1%, negative predictive value 77.1%, and accuracy 89.8%. Accuracy indices for ectopic parathyroid adenomas were sensitivity 81.5%, specificity 100%, positive predictive value 100%, negative predictive value 92.4%, and accuracy 94.3%. For the overall group, SPECT/CT demonstrated a sensitivity of 85.1% and a PPV of 98.7%. SPECT/CT correctly identified the abnormal parathyroid gland in 60% of patients with a normal serum PTH (<6.9 pmol/L), 73% between 6.9-9.9 pmol/L, 86% between 10.0-14.9 pmol/L, 100% between 15.0-19.9 pmol/L, 88% between 20.0-24.5 pmol/L, and 100% of patients with a PTH greater than 25.0 pmol/L. Conclusions: Dual-phase 99m Tc-MIBI with SPECT/CT is an accurate and reliable means to correctly localize both retrothyroid and ectopic parathyroid adenomas for the purpose of surgical planning. The accuracy of SPECT/CT increases with increasing serum PTH levels. R esum e Objet : L' etude avait pour objectif 1) de d eterminer la pr ecision de la m ethode de double phase par tomographie d' emission a photon unique (TEPU-TDM) au techn etium 99 m ( 99m Tc) avec isocyanure de m ethoxyisobutyle (MIBI) pour la localisation pr eop eratoire des ad enomes parathyro€ ıdiens menant a l'hyperparathyro€ ıdie primaire, 2) de d eterminer la pr ecision des examens de localisation des glandes ectopiques et 3) d' evaluer le lien entre la pr ecision des examens et les niveaux de parathormone (PTH) dans le s erum. M ethodes : Quatre-vingt-huit patients qui ont subi un examen TEPU-TDM 99m Tc-MIBI pour hyperparathyro€ ıdie primaire dans notre etablissement sur une p eriode de 27 mois ont fait l'objet d'une evaluation r etrospective. Les r esultats des examens TEPU-TDM pr eop eratoires ont et e compar es avec les observations perop eratoires (durant l'ann ee suivant les examens). Le lien entre les niveaux de PTH dans le s erum (dans les trois mois suivants) et l'exactitude des examens TEPU-TDM a ensuite et e evalu e. R esultats : Pour le sous-groupe de localisation d'ad enomes r etro-thyro€ ıdiens, les indices de pr ecision etaient les suivants: sensibilit e 86,7 %, sp ecificit e 96,4 %, valeur pr edictive positive 98,1 %, valeur pr edictive n egative 77,1 % et pr ecision 89,8 %. Pour les examens de localisation des ad enomes parathyro€ ıdiens ectopiques, les indices de pr ecision etaient les suivants: sensibilit e 81,5 %, sp ecificit e 100 %, valeur pr edictive positive 100 %, valeur pr edictive n egative 92,4 % et pr ecision 94,3 %. Pour l'ensemble du groupe, les r esultats relatifs a la TEPU-TDM ont indiqu e une sensibilit e de 85,1 % et une valeur pr edictive positive de 98,7 %. La TEPU-TDM a r ev el e des glandes parathyro€ ıdes anormales chez 60 % des patients au niveau de PTH normal (<6,9 pmol/L), 73 % des patients au niveau de PTH entre 6,9 et
Primary hyperparathyroidism (HPT), caused by hypersecretion of parathyroid hormone (PTH) from autonomously functioning parathyroid tissue, is a common endocrine disorder affecting 0.3% of the general population with a strong female predominance (4:1 female:male) [1] .
In up to 90% of cases, primary HPT is caused by a single parathyroid adenoma, however primary HPT may also occur as the result of sporadic parathyroid carcinoma (<1%), multiple endocrine neoplasias, or as a sequelae of metabolic diseases or genetic syndromes [2, 3] . A total of 80%-85% of parathyroid adenomas are located immediately posterior to the thyroid gland (retrothyroid); however, 15%-20% are ectopically positioned. Ectopic parathyroid glands can be found in a number of locations including the tracheoesophageal groove, adjacent to or within the carotid sheath, within the thyroid gland, or within the mediastinum [4] .
Histopathologic distinction between parathyroid hyperplasia and a parathyroid adenoma is not well defined. Single gland disease is often felt to represent a parathyroid adenoma while multi gland disease is thought reflect parathyroid hyperplasia. Mariani et al [4] suggest these may reflect variable phenotypic expression of the same disease entity.
Management of primary HPT is routinely surgical. Due to a number of factors including improved cosmesis, decreased postsurgical pain, shorter operating time, decreased hospitalization, and comparable success rates, minimally invasive parathyroidectomy has replaced conventional bilateral neck dissection as the standard approach. Preoperative localization of hyperfunctioning parathyroid adenomas is critical in planning for minimally invasive surgery [5] . Despite this necessity there remains a high degree of variability in the clinical management of primary HPT in Canada [6] . 99m Tc -methoxyisobutylisonitrile (MIBI) scintigraphy is the mainstay molecular imaging technique for this clinical problem utilizing either dual-phase or subtraction techniques [7, 8] . Recently, incorporation of single-photon emission computed tomography/computed tomography (SPECT/CT) into this imaging technique has become common practice, improving localization and resulting in increased utilization of minimally invasive surgical techniques [9] .
PTH is a polypeptide released from parathyroid glands, which has multiple actions in calcium metabolism including increased renal tubular calcium absorption, stimulation of renal 1,25 dihydroxyvitamin D production, and regulation of bone remodelling [10] . Inappropriately elevated serum PTH is a marker of primary HPT [11] . One report has suggested increased PTH levels in patients with positive MIBI scans compared to those with negative MIBI scans [12] . This report did not evaluate SPECT/CT.
The goals of our study were 3-fold: (a) to determine the overall accuracy of dual-phase MIBI scintigraphy with SPECT/CT for the preoperative localization of parathyroid adenoma in the setting of primary HPT, (b) to determine the accuracy of localization for ectopic glands, and (c) to assess the relationship between accuracy and serum PTH levels.
Methods

Study Population
Four hundred consecutive patients who underwent 99m Tc-MIBI SPECT/CT imaging for HPT over a 27-month period at our institution were retrospectively reviewed. The study protocol was approved by our institutional ethics review board. Patients were excluded from analysis based on the following criteria: no surgery after the SPECT/CT study, delay between the SPECT/CT study and surgery of greater than 1 year, history of previous parathyroid or thyroid surgery prior to the SPECT/CT study, or history of end-stage renal disease or dialysis.
Data Collection
Data parameters obtained from the patient medical record included: gender, date of birth, imaging findings, surgical findings, pathology findings, pre-SPECT/CT PTH levels, past surgical history, and the surgical approach chosen. The surgical report, outlining the intraoperative findings, was used as the reference standard with respect to parathyroid gland localization. Glands were categorized as retrothyroid left, retrothyroid right, or ectopic in location. The preoperative SPECT/CT report was then compared with surgical findings to determine the detection and localization accuracy. For the purpose of the results, ectopic parathyroid glands were not subcategorized based on their specific location. Any parathyroid gland not located in the classical immediate retrothyroid location was considered ectopic. In order to ensure correct categorization of the imaging findings, the images were reviewed in the event of a discrepancy between the imaging report and the surgical report. The images were also reviewed if the described location in the report was difficult to categorize. Although the terms ''parathyroid adenoma'' and ''parathyroid hyperplasia'' were often used interchangeably on the pathological reports, if a single gland was involved the abnormal gland was categorized as a parathyroid adenoma for the purpose of our results.
Definition of Test Accuracy: Overall Group
An abnormal parathyroid gland was surgically removed in all of the included patients, however, a parathyroid adenoma was not necessarily detected preoperatively in every case. If the location of the parathyroid adenoma identified at surgery corresponded to the parathyroid adenoma detected on SPECT/CT, we categorized the result as a true positive. If the surgically removed parathyroid gland was in a different location than that specified on the preoperative SPECT/CT, the result was categorized as a false positive. In the event that an abnormal parathyroid gland was removed at surgery but not detected on SPECT/CT, the result was categorized as a false negative. As an abnormal parathyroid gland was removed in all patients, no true negatives were included in the overall assessment. Thus, specificity, negative predictive value (NPV), and accuracy could not be evaluated for the overall group.
Definition of Test Accuracy: Retrothyroid Group
For the retrothyroid group, positive retrothyroid SPECT/ CT localization on the same side as a retrothyroid surgical adenoma was considered a true positive. Positive retrothyroid localization with surgical retrothyroid localization on the contralateral side or in an ectopic location was considered false positive. No retrothyroid SPECT/CT localization in a patient with an ectopic adenoma was considered true negative. No retrothyroid SPECT/CT localization in a patient with a retrothyroid adenoma surgically was considered false negative.
Definition of Test Accuracy: Ectopic Group
For the ectopic group, SPECT/CT localization in a nonclassical retrothyroid location with a similar ectopic location at surgery was considered true positive. The SPECT/ CT reports were compared with the surgical reports to ensure the described locations were similar. A positive ectopic SPECT/CT study was considered false positive when the surgical report described the adenoma at classically retrothyroid in location or in a different ectopic location. The studies were considered true negative when the SPECT/CT scan described retrothyroid or no localization and the surgical report described the adenoma as retrothyroid. The studies were considered false negative when no ectopic gland was identified on the SPECT/CT scan but was identified at surgery.
PTH Correlation
A serum PTH level of 6.8 pmol/L is considered to be the upper limits of normal at our institution. In order to evaluate the relationship between serum PTH level and the accuracy of SPECT/CT for identifying and localizing parathyroid adenomas prior to surgery, patients were divided into subgroups based on their serum PTH level. Patients were included in this subgroup analysis if they had available serum PTH results within 3 months prior to the SPECT/CT study. Patients who had what is considered to be a normal serum PTH level, <6.9 pmol/L at our institution, constituted the first group. We divided the remaining patients into subgroups based on arbitrary threshold values of 10, 15, 20, and 25 pmol/L.
Imaging Techniques
The routine dual-phase parathyroid SPECT/CT protocol at our institution involves intravenous administration of 1110 Mbq (30 mCi) of 99m Tc-labeled sestamibi. Pin-hole planar images of the neck (200,000 counts, 256 Â 256 matrix) and low-energy high-resolution parallel hole collimated planar images of the neck and mediastinum (5-minute acquisition, 256 Â 256 matrix) are acquired 15 minutes and 2 hours following radiotracer administration, resulting in a total of 4 planar images. Planar images are typically acquired using a dual-head Philips Brightview XCT gamma camera (Philips, Best, the Netherlands) with a photopeak centred at 140 keV and a window of 20%. Subtraction imaging is not routinely performed at our institution.
SPECT/CT images are acquired between the early phase and late phase planar images. SPECT/CT is typically performed with a Philips Precedence 16-slice SPECT/CT system (Philips, Best, The Netherlands). The SPECT acquisition parameters include: low-energy high-resolution collimation, 30 seconds per frame, 128 frames, 128 Â 128 matrix. The SPECT images are reconstructed using ASTONISH iterative reconstruction with a uniform start, 4 iterations, and 16 subsets. Decay and attenuation corrections are applied. The CT acquisition parameters include: 140 kV, 60-100 mAs (depending on patient size), 16 Â 1.5 mm collimation, 600 mm FOV, 512 Â 512 matrix, 0.938 pitch, 0.5 s rotation speed, no intravenous contrast. The CT images are reconstructed using standard filters at 2 mm slice thickness with 1 mm slice intervals. The SPECT dataset, CT datasets, and fused SPECT/CT dataset included in this study were reviewed using Extended Brilliance Workstation Fusion Viewer software (Philips, Best, the Netherlands).
Surgical Techniques
Surgery was performed utilizing either conventional neck dissection or minimally invasive techniques. Typically intraoperative PTH monitoring pre-and postresection was performed to verify resection of the correct culprit lesion. As this was a retrospective study the surgeons were not aware of the study at the time of surgery. A variety of different surgeons were involved with varying levels of experience including both general surgeons and otolaryngologists. The surgeons were not blinded to the SPECT/CT results.
Statistics
Mean values were compared with a 2-tailed Student t test. P values <.05 were considered significant.
Results
Eighty-eight of the 400 (22%) consecutive patients who underwent SPECT/CT met our study criteria (Figure 1 ). This group was predominantly female (67 of 88; 76%) and had an average age of 56.5 years (range 19-88, SD 16.2). The 21 male patients (21 of 88; 24%) were on average slightly younger with a mean age of 49.9 years, while the female patients had an average age of 58.5 years. Minimally invasive surgery was performed in 57% of patients (50 of 88) while the remaining 43% of patients (38 of 88) were treated with a conventional neck dissection. The surgically excised specimens demonstrated parathyroid adenoma in 87 patients and parathyroid carcinoma in 1 patient. The images were reviewed in 32 patients out of the cohort that had surgery (32 of 113; 28%) in order to ensure correct categorization of the imaging findings.
Accuracy: Overall Group
Preoperative SPECT/CT correctly localized 74 of the 88 abnormal parathyroid glands as either classical retrothyroid left, classical retrothyroid right, or ectopic in location. Thirteen were not detected preoperatively. One parathyroid adenoma (1 of 88; 1%) was localized to the incorrect side. In this case, the SPECT/CT study localized activity to a soft tissue nodule at the right inferior thyroid bed region. A focus of activity was also noted posterior to the left piriform sinus but no corresponding soft tissue abnormality was seen and this was considered spurious. Surgery demonstrated the right-sided abnormality to reflect benign thyroid tissue (possibly a thyroid adenoma) with further left-sided surgical exploration identifying a left upper retrothyroid parathyroid adenoma. On one occasion, the SPECT/CT correctly identified an intrathymic parathyroid adenoma while raising the possibility of a second involved gland posterior to the right lobe of the thyroid. At the time of surgery this second focus was shown to represent Zuckerkandl's tubercle. The overall sensitivity was 85.1% (74 of 87) with a positive predictive value (PPV) of 98.7% (74 of 75) and an accuracy of 84.1% (74 of 88). As the reference standard was the surgical findings and a lesion was identified in all patients at the time of surgery, the specificity, NPV, and accuracy could not be calculated for the overall group (no defined true negative rate) ( Table 1) . 
Accuracy: Retrothyroid Group
Accuracy: Ectopic Group
For ectopic adenomas, SPECT/CT had a sensitivity of 81.5% (22 of 27), a specificity of 100% (61 of 61), a positive predictive value of 100% (22 of 22), a negative predictive value of 92.4% (61 of 66), and an accuracy of 94.3% (83 of 88) (Figure 3 ). 
Sensitivity Stratified by Serum PTH
Seventy of the patients included in the study had a serum PTH drawn within the 3-month period prior to their SPECT/ CT study and were included in the subgroup analysis. A total of 86% (60 of 70) of the abnormal parathyroid glands were correctly identified and localized on the SPECT/CT.
A parathyroid adenoma was correctly identified in 3 patients (3 of 5; 60%) who had a normal serum PTH prior to the SPECT/CT, which was considered to be less than 6.9 pmol/L at our institution. Regarding patients with an elevated serum PTH level, the PTH range and corresponding rate of accurate localization of parathyroid adenomas is as follows: an abnormal parathyroid gland was correctly identified in 11 of 15 patients (73%) with a PTH between 6.9-9.9 pmol/L, 19 of 22 patients (86%) with a PTH between 10.0-14.9 pmol/L, 11 of 11 patients (100%) with a PTH between 15.0-19.9 pmol/L, 7 of 8 patients (88%) with a PTH between 20.0-24.5 pmol/L, and in 9 of 9 patients (100%) with a PTH greater than 25 pmol/L (Figure 4 ).
Serum PTH levels greater than 10 pmol/L were associated with a statistically significant increase in the detection and correct localization of parathyroid adenomas (P < .02) compared with serum PTH levels less than 10 pmol/L.
Discussion
Dual-phase parathyroid imaging with 99m Tc-MIBI and SPECT/CT is an accurate and reliable method for the preoperative assessment of hyperfunctioning parathyroid adenomas. It has been shown to be superior to ultrasonography, CT, and magnetic resonance imaging for identification and preoperative localization [13, 14] . The transition towards minimally invasive surgery places increased value on identifying and accurately localizing parathyroid adenomas prior to surgery. Results from our institution are concordant with the current literature, which suggests the sensitivity of parathyroid SPECT/CT ranges from 59.8%-97%, with a specificity between 83%-98.7% and an accuracy of 80%-83.3% [9,13,15e17] .
Our data suggests the identification and localization of classically located and ectopic parathyroid adenomas is similar using SPECT/CT. Because 15%-20% of parathyroid adenomas are ectopic, preoperative localization is an important distinction that may impact the surgical approach chosen [4] .
Although elevation of the serum PTH is used to diagnose HPT, a relationship between been the serum PTH level and accurate localization of parathyroid adenomas has not been well established in the literature. A single report (without utilization of SPECT/CT) has suggested significantly increased PTH levels in patients with positive MIBI scans compared to negative MIBI scans [12] . Five patients in our study population had a PTH level in the normal range (<6.9 pmol/L). In these patients, SPECT/CT was ordered as part of the investigation for unexplained hypercalcemia. A parathyroid adenoma was identified in all of these patients at the time of surgery, however, in only 3 of the 5 preoperative SPECT/CTs (60%) was an adenoma identified. The probability of detecting and accurately localizing a parathyroid adenoma improves as the serum PTH increases. When the serum concentration is greater than 10 pmol/L, the detection rate remains very high (92% or greater at all levels).
Based on these results, clinicians may be able to reduce the unnecessary cost and wait time associated with supplementary or redundant imaging tests in patients being evaluated for primary HPT and who have a significantly elevated serum PTH level (>10 pmol/L). In this patient population, SPECT/CT may be the first and only imaging modality required. However, patients who have a normal or mildly elevated serum PTH (<10 pmol/L) may benefit from additional or supplementary imaging modalities.
The major limitations of our study relate to the retrospective design. There is probable referral bias in our study population as it is likely positive studies will increase the likelihood of surgery. Given surgical results within 1 year were used as the reference standard and all patients had findings at surgery, the true negative rate could not be established for the overall group. It should be recognized that the reference standard of surgery itself may have some associated error. Persistent or recurrent HPT can occur as a result of inadequate resection or undetected multiglandular disease in up to 5%-10% of patients [2] . The common utilization of intraoperative PTH monitoring (typical at our institution) minimizes this type of error. Finally, the fact that the study population was derived from a SPECT/CT clinical database may introduce some selection bias. Some clinicians may reserve the use of SPECT/CT only for equivocal or difficult cases. The large patient population assessed in our study should mitigate this potential bias.
Conclusion
As the trend towards minimally invasive parathyroidectomy continues, the importance of accurate and reliable preoperative imaging increases. Results from our institution are consistent with the current literature regarding the overall high sensitivity, specificity, and accuracy of SPECT/CT. These values apply to both classically located retrothyroid and ectopic parathyroid adenomas.
Our data also demonstrate the detection and accurate localization of parathyroid adenomas improves with increased serum PTH particularly above a value of 10 pmol/L. For patients with serum PTH above this level, SPECT/CT should likely be the primary diagnostic imaging test. In the setting of patients with a normal or minimally elevated PTH, the addition of correlative imaging studies such as ultrasound may be more beneficial.
